Type
Business expansion
Country
France
Region
île de France; Yvelines;
Location of affected unit(s)
Vélizy-Villacoublay
Sector
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72.19 - Other research and experimental development on natural sciences and engineering

180 jobs
Number of planned job creations
Job creation
Announcement Date
18 December 2018
Employment effect (start)
1 January 2019
Foreseen end date
1 January 2025

Description

Carmat, which develops and markets its artificial heart technology, has announced a doubling of its workforce by 2025, after obtaining €30 million from the European Investment Bank (EIB). The loan is supported by the European Strategic Investment Fund, provided for in the Juncker Plan. This loan has two objectives: to enable the ongoing clinical trial to be finalised in order to obtain CE marking; to promote the transformation of Carmat into an industrial and commercial company by increasing its production capacity. The company thus plans to recruit 180 more people by 2025, mainly in the R&D branch.


Sources

Citation

Eurofound (2018), Carmat, Business expansion in France, factsheet number 96232, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/96232.